Class II · Moderate risk
APAP 325 mg
CGMP Deviations
FDA Drug Recalls
18,003 recalls, newest first
Class II · Moderate risk
APAP 500 mg Phenyl HCl 5mg tablet
CGMP Deviations
Class II · Moderate risk
APAP 325 mg/Phenylephrine HCl
CGMP Deviations
Class II · Moderate risk
Coated APAP 325 mg Phenyl HCl 5 mg tablet
CGMP Deviations
Class II · Moderate risk
Dologen 325 Caplet
CGMP Deviations
Class II · Moderate risk
Kramer Novis Tusicof Caplet
CGMP Deviations
Class II · Moderate risk
Zee Cold Tabs
CGMP Deviations
Class II · Moderate risk
4-Component Cold Tabs
CGMP Deviations
Class II · Moderate risk
3-Component Cold Tabs
CGMP Deviations
Class II · Moderate risk
Inhub Wixela
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Class II · Moderate risk
Warfarin Sodium Tablets
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Class II · Moderate risk
Warfarin Sodium Tablets
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Class II · Moderate risk
Triamterene and Hydrochlorothiazide Capsules
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Class II · Moderate risk
Terconazole Vaginal Suppositories
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Class II · Moderate risk
Spiriva Handihaler
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Class II · Moderate risk
Rivastigmine Transdermal System
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Class II · Moderate risk
Ricola CherryHoney Herb Throat Drops
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Class II · Moderate risk
Propranolol Hydrochloride Tablets
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Class II · Moderate risk
PredniSONE Tablets
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Class II · Moderate risk
Nyamyc
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Class II · Moderate risk
Metoprolol Succinate Extended-Release Tablets
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Class II · Moderate risk
Meloxicam Tablets
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Class II · Moderate risk
Lithium Carbonate Extended-Release Tablets
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Class II · Moderate risk
Lisinopril and Hydrochlorothiazide Tablets USP
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Class II · Moderate risk
Lillow (Levonorgestrel and Ethinyl Estradiol Tablets, USP)
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.